| Quote
: |
黎鹏程,何清湖,孙贵香,叶培汉,刘向华,杨玉芳,孙光荣.国医大师孙光荣论“中医优势病种”[J].湖南中医药大学学报英文版,2018,38(1):1-3.[Click to copy
] |
|
| |
|
|
| This paper
：Browser 2713times Download 702times |
| 国医大师孙光荣论“中医优势病种” |
| 黎鹏程,何清湖,孙贵香,叶培汉,刘向华,杨玉芳,孙光荣 |
| (湖南中医药大学, 湖南 长沙 410208;国医大师孙光荣湖南工作室, 湖南 长沙 410208) |
| 摘要: |
| 系统介绍孙光荣教授有关“中医优势病种”的论述。“中医优势病种”是指中医治疗疗效确切、药物毒副作用相对较小的病种；或西医治疗尚未有好方法、好疗效，但中医却能明显改善某个症状的病种；以及艾滋病、非典等传染性疾病。“中医优势病种”主要包含病毒感染性疾病、功能失调性疾病、疾病缓解期或慢性期、原因不明的各类疾病、病情复杂的疑难杂症以及疾病的综合调理等方面。 |
| 关键词: 中医 优势病种 病毒 慢性病 功能失调性疾病 孙光荣 |
| DOI：10.3969/j.issn.1674-070X.2017.01.001 |
| Received:June 16, 2017 |
| 基金项目:中央省补助中医药专项经费“国医大师孙光荣湖南工作室”；国家中医药管理局“国医大师孙光荣工作室建设项目”资助；湖南中医药大学中医诊断学国家重点学科开放基金项目（2013ZYZD21）；湖南省学位与研究生教改项目（JG2014B043）；湖南省卫计委科研项目（B201546）；国家中医药管理局2014年中医药行业科研专项（201407004）。 |
|
| Discussion on “Dominant Diseases in Traditional Chinese Medicine” by National Chinese Medicine Master Sun Guangrong |
| LI Pengcheng,HE Qinghu,SUN Guixiang,YE Peihan,LIU Xianghua,YANG Yufang,SUN Guangrong |
| (Hunan University of Chinese Medicine, Changsha, Hunan 410208, China;National Chinese Medicine Master Sun Guangrong Studio of Hunan, Changsha, Hunan 410208, China) |
| Abstract: |
| This paper systematically described Professor Sun Guangrong's discussion on the "dominant diseases in traditional Chinese medicine". "Dominant diseases in traditional Chinese medicine" refered to the diseases treated with TCM showed good curative effect,less toxic and side effect,or the diseases treated with Western medicine had no good effects,but TCM could improve a symptom or a stage of the diseases,and acquired immune deficiency syndrome (AIDS),severe acute respiratory syndrome (SARS). "Dominant diseases in traditional Chinese medicine" mainly included viral infection,disease dysfunction,disease remission or chronic stage,a variety of "unexplained" syndromes,complicated diseases,difficult miscellaneous diseases,comprehensive regulation of diseases. |
| Key words: traditional Chinese medicine dominant diseases virus chronic disease dysfunctional disease Sun Guangrong |
|
二维码（扫一下试试看！） |
|
|
|
|
